N/A
Completed N=131
Mechanisms of Severe Acute Influenza Consortium (MOSAIC)
Source: ClinicalTrials.gov NCT00965354 ↗Enrolled (actual)
131
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcomePrimary: Number of Patients With Clinical Phenotype Presenting Also a Sequential Activation of Immune/Infammatory Pathways. — 131 Participants
Summary
The ultimate goal of this collaborative, intensive study is to discover new and effective treatments and to develop better vaccines that can be used in future outbreaks of Influenza A. By integrating the information that we will gather, we will create a unique overview of how influenza causes illness and what might be done to improve patient management.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients With Clinical Phenotype Presenting Also a Sequential Activation of Immune/Infammatory Pathways. |
131 | — |
Eligibility Criteria
Inclusion Criteria
- Any patient admitted to hospital with suspected or confirmed influenza infection
Exclusion Criteria
- Patients who do not give their consent
Data sourced from ClinicalTrials.gov (NCT00965354). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.